Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Ruiju Jiang"'
Autor:
Qiongzhou Yin, Yan Zheng, Zhifang Ying, Jingyu Li, Ya Jiang, Wenmei Bao, Youjian Dou, Yi Pu, Jin Lei, Haitao Yang, Ruiju Jiang, Yan Deng, Zhimei Zhao, Jing Pu, Jing Yang, Yadong Li, Min Xu, Wei Cai, Yanchun Che, Li Shi
Publikováno v:
Vaccines, Vol 12, Iss 2, p 217 (2024)
Background: An inactivated poliomyelitis vaccine made from Sabin strains (sIPVs) has widely been used in China since 2015. However, the quantitative data on the instant and persistent inhibition effects of maternal poliovirus antibodies on the immune
Externí odkaz:
https://doaj.org/article/9f0bacde7e3b4faaa5c55e5976696f11
Autor:
Hongbo Chen, Zhongping Xie, Runxiang Long, Shengtao Fan, Heng Li, Zhanlong He, Kangwei Xu, Yun Liao, Lichun Wang, Ying Zhang, Xueqi Li, Xingqi Dong, Tangwei Mou, Xiaofang Zhou, Yaoyun Yang, Lei Guo, Jianbo Yang, Huiwen Zheng, Xingli Xu, Jing Li, Yan Liang, Dandan Li, Zhimei Zhao, Chao Hong, Heng Zhao, Guorun Jiang, Yanchun Che, Fengmei Yang, Yunguang Hu, Xi Wang, Jing Pu, Kaili Ma, Lin Wang, Chen Cheng, Weiguo Duan, Dong Shen, Hongling Zhao, Ruiju Jiang, Xinqiang Deng, Yan Li, Hailian Zhu, Jian Zhou, Li Yu, Mingjue Xu, Huijuan Yang, Li Yi, Zhenxin Zhou, Jiafang Yang, Nan Duan, Huan Yang, Wangli Zhao, Wei Yang, Changgui Li, Longding Liu, Qihan Li
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss , Pp 108-118 (2021)
Because of the relatively limited understanding of coronavirus disease 2019 (COVID-19) pathogenesis, immunological analysis for vaccine development is needed. Mice and macaques were immunized with an inactivated severe acute respiratory syndrome coro
Externí odkaz:
https://doaj.org/article/3fc49a558fe94530b43e2155c4a61878
Autor:
Xiaofang Zhou, Li Yu, Zhimei Zhao, Wangli Zhao, Nan Duan, Zhanlong He, Zhongping Xie, Lin Wang, Dong Shen, Xueqi Li, Zhenxin Zhou, Longding Liu, Mingjue Xu, Weiguo Duan, Xingqi Dong, Hongling Zhao, Changgui Li, Yun Liao, Kaili Ma, Hailian Zhu, Lei Guo, Xi Wang, Yaoyun Yang, Qihan Li, Huan Yang, Tangwei Mou, Huijuan Yang, Yanchun Che, Yan Liang, Heng Li, Xinqiang Deng, Heng Zhao, Jianbo Yang, Li Yi, Fengmei Yang, Lichun Wang, Jing Pu, Kangwei Xu, Jing Li, Ruiju Jiang, Yunguang Hu, Shengtao Fan, Huiwen Zheng, Runxiang Long, Jian Zhou, Chen Cheng, Xingli Xu, Hongbo Chen, Guorun Jiang, Chao Hong, Jiafang Yang, Yan Li, Dandan Li, Wei Yang, Ying Zhang
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss, Pp 108-118 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Because of the relatively limited understanding of COVID-19 pathogenesis, immunological analysis for vaccine development is needed. Mice and macaques were immunized with an inactivated SARS-CoV-2 vaccine prepared by two inactivators. Various immunolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c70d573a58f974292ba5a12ec68e857
http://www.sciencedirect.com/science/article/pii/S2329050121001315
http://www.sciencedirect.com/science/article/pii/S2329050121001315
Autor:
Jingsi Yang, Yuping zhao, Jing Li, Teng Huang, Ting Zhao, Yanchun Che, Zhimei Zhao, Yu ting Fu, Jun hui Tao, Qing hai Yang, Ding kai Wei, Guoliang Li, Xiaolei Yang, Li Yi, Hongbo Chen, Jianfeng Wang, Ruiju Jiang, Lei Yu, Wei Cai, Wei Yang, Ming xue Xie, Qiongzhou Yin, Jing Pu, Li Shi, Chao Hong, Yan Deng, Lukui Cai, Jian Zhou, Yu Wen, Hong sen Li, Wei Huang, Zhao jun Mo, Qihan Li
To provide a basis for further optimization of the polio sequential immunization schedule, this study evaluated the effectiveness of booster immunization with one dose of bivalent oral poliovirus vaccine (bOPV) at 48 months of age after different pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8d0cb92a4f3eacc437169d05b85cd458
https://doi.org/10.21203/rs.3.rs-2032645/v1
https://doi.org/10.21203/rs.3.rs-2032645/v1
Autor:
Jing Pu, Zhimei Zhao, Shengtao Fan, Jian Zhou, Yunfei Ma, Dan Du, Changgui Li, Yan Li, Ruiju Jiang, Hongbo Chen, Pingfang Cui, Runxiang Long, Kai-Li Ma, Jing Li, Zhanlong He, Mingjue Xu, Yanchun Che, Jianfeng Wang, Guorun Jiang, Ying Zhang, Lei Guo, Zhuo Chen, Zhifang Yin, Xuan-Yi Wang, Xueqi Li, Qihan Li, Shiyin Feng, Yang Gao, Shibao Yao, Zhongping Xie, Huijuan Yang, Yun Liao, Xingli Xu, Chao Hong, Linrui Cai, Lingli Zhang, Li Yu, Huiwen Zheng, Qiongzhou Yin, Shan Lu, Heng Zhao, Longding Liu, Qin Yu, Donglan Liu, Hongling Zhao, Tangwei Mou, Lichun Wang
Publikováno v:
Vaccine
BACKGROUND: This study examined the safety and immunogenicity of an inactivated SARS-CoV-2 vaccine. METHOD: In a phase I randomized, double-blinded, placebo-controlled trial involving 192 healthy adults 18-59 years old, two injections of three doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2db1d5b67d428e6e93f51c4d62fa101c
https://pubmed.ncbi.nlm.nih.gov/33875266
https://pubmed.ncbi.nlm.nih.gov/33875266
Autor:
Pingfang Cui, Runxiang Long, Lingli Zhang, Changgui Li, Tangwei Mou, Jing Li, Li Yu, Huiwen Zheng, Zhimei Zhao, Linrui Cai, Zhuo Chen, Shengtao Fan, Qiongzhou Yin, Shibao Yao, Yang Gao, Xueqi Li, Hongling Zhao, Donglan Liu, Shan Lu, Lichun Wang, Ruiju Jiang, Hongbo Chen, Qin Yu, Heng Zhao, Jianfeng Wang, Longding Liu, Yunfei Ma, Yanchun Che, Ying Zhang, Zhongping Xie, Kai-Li Ma, Qihan Li, Huijuan Yang, Yun Liao, Jing Pu, Zhanlong He, Zhifang Yin, Chao Hong, Lei Guo, Xingli Xu, Dandan Li, Shiyin Feng, Yan Li, Mingjue Xu, Xuanyi Wang, Jian Zhou, Dan Du, Guorun Jiang
BACKGROUNDIn-depth investigations of the safety and immunogenicity of inactivated SARS-CoV-2 vaccines are needed.METHODIn a phase I randomized, double-blinded, and placebo-controlled trial involving 192 healthy adults 18-59 years of age, two injectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::718dbdf0cec127cec1607d5927407c99
https://doi.org/10.1101/2020.09.27.20189548
https://doi.org/10.1101/2020.09.27.20189548
Autor:
Yan Zheng, Pingfang Cui, Runxiang Long, Ruiju Jiang, Hongbo Chen, Dandan Li, Ying Zhang, Chen Cheng, Yuehui Zhang, Yi Pu, Weiwu Chen, Jianfeng Wang, Zhanlong He, Jing Pu, Meijian Zhou, Qihan Li, Guorun Jiang, Donglan Liu, Zhifang Yin, Yan Li, Jin Lei, Zhimei Zhao, Shengtao Fan, Yanchun Che, Li Yu, Ya Jiang, Heng Zhao, Yaling Zhou, Yanxiang Zou, Kai-Li Ma, Ting Yang, Zhongping Xie, Huijuan Yang, Yun Liao, Xingli Xu, Changgui Li, Jianbo Yang, Chao Hong, Qiongzhou Yin, Yingqiu Guo, Mingjue Xu, Jingyu Li, Youshuai Zhu, Hongling Zhao, Xiaoqiang Liu, Lichun Wang
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Clinical Infectious Diseases
Clinical Infectious Diseases
Background We evaluated an inactivated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine for immunogenicity and safety in adults aged 18–59 years. Methods In this randomized, double-blinded, controlled trial, healthy adults recei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37db448e6db1e48d7053d17afd688149
https://pubmed.ncbi.nlm.nih.gov/33515255
https://pubmed.ncbi.nlm.nih.gov/33515255
Autor:
Hongbo Chen, Zhongping Xie, Runxiang Long, Shengtao Fan, Heng Li, Zhanlong He, Kanwei Xu, Yun Liao, Lichun Wang, Ying Zhang, Xueqi Li, Xingqi Dong, Tangwei Mou, Xiaofang Zhou, Yaoyun Yang, Lei Guo, Jianbo Yang, Huiwen Zheng, Xingli Xu, Jing Li, Yan Liang, Dandan Li, Zhimei Zhao, Chao Hong, Heng Zhao, Guorun Jiang, Yanchun Che, Fengmei Yang, Yunguang Hu, Xi Wang, Jing Pu, Kaili Ma, Lin Wang, Chen Chen, Weiguo Duan, Dong Shen, Hongling Zhao, Ruiju Jiang, Xinqiang Deng, Yan Li, Hailian Zhu, Jian Zhou, Li Yu, Mingjue Xu, Huijuan Yang, Li Yi, Zhenxin Zhou, Jiafang Yang, Nan Duan, Huan Yang, Wangli Zhao, Wei Yang, Changgui Li, Longding Liu, Qihan Li
With the relatively serious global epidemic outbreak of SARS-CoV-2 infection, public concerns focus on not only clinical therapeutic measures and public quarantine for this disease but also the development of vaccines. The technical design of our SAR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5496f754e8ac8c2fc0ab08b27e244a2b
https://doi.org/10.1101/2020.08.04.235747
https://doi.org/10.1101/2020.08.04.235747
Autor:
Ruiju Jiang, Xijun You, Wangsheng Zhang, Yong Dai, Yeqing Tong, Wenhua Luo, Siquan Wang, Qiaoxin Huang, Yang Wu, Zhimei Zhao, Shengtao Fan, Shaoping Li, Wensheng Gong, Ying Liu, Yanting Zhao, Jiahong Li, Xingli Xu, Ying Zhang, Fan Liu, Lei Wang, Qihan Li, Guoping Min, Guorun Jiang, Xingzhou Hu, Yanchun Che, Xuhua Guan, Lianju Hang, Jiao Huang, Sheng Wei, Changhui Li, Yun Liao
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 71(9)
Background Evaluation of a licensed inactivated enterovirus type 71 (EV71) vaccine is needed in a phase IV study with a large population to identify its effectiveness and safety for further application. Methods An open-label, controlled trial involvi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e6163eb184b3e003a0ea12112598ad
https://pubmed.ncbi.nlm.nih.gov/31734699
https://pubmed.ncbi.nlm.nih.gov/31734699
Autor:
Yonghong Ge, Yamin Wang, Yan Li, Chenyan Yue, Huirong Pan, Peicheng Liu, Lingjiu Liu, Zhijie An, Qiyou Xiao, Ruiju Jiang
Publikováno v:
Immunization Program in China ISBN: 9789811324376
Yongxin Yu is an academician at the Chinese Academy of Engineering and a highly respected person when it comes to Japanese encephalitis (JE) live attenuated vaccine (Fig. 5.1). After the JE vaccine he developed was approved and marketed in 1989, hund
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0df79f0e14b5d32d7b8acd1378be4194
https://doi.org/10.1007/978-981-13-2438-3_5
https://doi.org/10.1007/978-981-13-2438-3_5